All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia
New England Journal of Medicine · 04.06.2026 · 394 (21) · 2107-2116
DOI: 10.1056/nejmoa2510223 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 04.06.2026. Verfasst von Gail J Roboz und 22 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine, New York Presbyterian Hospital, New York. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Bridged Bicyclo Compounds, Heterocyclic, Decitabine, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Taiho Oncology, Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Weill Cornell Medicine, New York Presbyterian Hospital, New York.
- Yale University and Yale Comprehensive Cancer Center, New Haven, CT.
- Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.
- Hospital Universitari i Politecnic La Fe, Valencia, Spain.
- Institut Català d'Oncologia, L'Hospitalet de Llobregat, Institut d'Investigació Biomèdica de Bellvitge, Universitat de Barcelona, Barcelona.
- Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville.
Förderung
- Taiho Oncology, Inc
Zitieren
APA
Roboz, G. J., Zeidan, A. M., Mannis, G. N., Montesinos, P., Arnan, M., Savona, M. R., Odenike, O., McCloskey, J. K., Amin, H. V., Fathi, A. T., Bernal Del Castillo, T., Rodríguez-Macías, G., Liesveld, J. L., Im, A. P., Cerny, J., Gentile, T. C., Oganesian, A., Chan, D., Wan, Y., …, & DiNardo, C. D. (2026). All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia. New England Journal of Medicine, 394(21), 2107-2116. https://doi.org/10.1056/nejmoa2510223
Vancouver
Roboz GJ, Zeidan AM, Mannis GN, Montesinos P, Arnan M, Savona MR, et al. All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia. New England Journal of Medicine. 2026;394(21):2107-2116. doi:10.1056/nejmoa2510223
BibTeX
@article{Roboz2026,
author = {Roboz, Gail J and Zeidan, Amer M and Mannis, Gabriel N and Montesinos, Pau and Arnan, Montserrat and Savona, Michael R and Odenike, Olatoyosi and McCloskey, James K and Amin, Harshad V and Fathi, Amir T and Bernal Del Castillo, Teresa and Rodríguez-Macías, Gabriela and Liesveld, Jane L and Im, Annie P and Cerny, Jan and Gentile, Teresa C and Oganesian, Aram and Chan, Danna and Wan, Yubing and Dijkstra, Margit and Keer, Harold N and Griffiths, Elizabeth A and DiNardo, Courtney D},
title = {All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {21},
pages = {2107--2116},
doi = {10.1056/nejmoa2510223}
}
EUVIMED